James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

8 Stocks to Buy That Are Growing Faster Than Amazon

Neurocrine Biosciences, Facebook and Etsy are just some of the stocks to buy if you want growth because they're outpacing Amazon.

3 Big Stock Charts for Friday: eBay, Intel and Mohawk Industries

The stock charts of EBAY, MHK and INTC are poised to end the trading week at key technical junctures.

10 Tech Stocks That Are Still Worth Your Time (And Money)

Alphabet, Dell and FireEye are just some of the top tech stocks to buy, even if the rest of the sector is overbought or overvalued, or both.

The Big Comeback for GE Stock Is Going to Keep Stalling

General Electric is doing what it's supposed to be doing, but until investors choose to see it, GE stock will remain stuck in the mud. Once they see it though, look out above.

The Worst Appears to Be Over for CVS Stock

Over the years, CVS stock has incurred some painful losses in the markets. However, bold moves by management make this a compelling contrarian buy.